Delivery Order SPE2DB20D1102-SPE2DB25FC6NG

Award Date 7/10/25
Potential Completion Date 7/11/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of hydralazine 20 mg/ml vials, a cardiovascular medication. The contract, valued at $2,796.24, was issued by the Medical Supply Chain of the Defense Logistics Agency (DLA) and has a completion date of December 13, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of Hydralazine 20 mg/mL vials, a medication, with a ceiling value of $2,252.40 and an ultimate completion date of September 9, 2024. The contract is a Firm Fixed Price (FFP) type, with no set-aside designation. Amerisourcebergen Drug Corp has been awarded numerous contracts by various federal...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,487.22 firm-fixed-price delivery order is for the supply of HYDRALAZINE 20 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of July 14, 2025 and is not a set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at one hundred forty-six dollars and forty cents ($146.40) to supply one thousand (1,000) tablets of fifty (50) milligram Hydralazine to the Defense Logistics Agency Troop Support Medical (DLA). Performance will take place in Conshohocken, Pennsylvania over a one day period concluding on August 31, 2023. The delivery order was issued under DLA's...
The Defense Logistics Agency awarded a $126 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20 mg/ml vials of hydralazine. The order is to be performed in Conshohocken, Pennsylvania from August 29-30, 2023. As a major provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver this medication to support the DLA's logistics operations. No subcontractors or set aside designations were indicated. The brief period of performance suggests this order...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $19,150 to Amerisourcebergen Drug Corporation to supply 100 tablets of 100 milligram Hydralazine. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical to its place of performance in Conshohocken, Pennsylvania within the period of performance from September 7-8, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely procures medicines and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of hydromorphone 1 mg/ml carpujctml. The contract has a firm fixed price of $1,998.74 and a period of performance through July 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which enables the company to supply a wide range of...
This federal contract award, with a ceiling value of $1,588.86, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the supply of pharmaceutical products, including medications such as Amlodipine-Valsartan-Hydrochlorothiazide 10-160-25 mg in 30-count packages. The contract is not set-aside and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,846.73, is for the delivery of AMLOD-VALSA-HCTZ 10-160-12.5MG 30S pharmaceutical products. The contract is a firm fixed-price, delivery order contract with a period of performance through December 2024. Amerisourcebergen Drug Corp is the prime contractor, and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Hydromorphone 1 mg/ml, a pain management medication, with a ceiling value of $2,705.56 and a period of performance through May 6, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D1102
    Indefinite Delivery Contract
  • SPE2DB20D1102-SPE2DB25FC6NG
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Hydralazine 20 mg/ml vial, a medication used to treat high blood pressure. The contract has a firm fixed price of $3,987.58 and a period of performance ending on July 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is not set aside and is open to full and open competition.

Generated 10/12/25, 1:01 AM